2023-10-18
同时,通过本次合作,该MNC将迅速推进无血清细胞培养基的新原料发现与验证,及培养基工艺的深度优化,将大幅提高生物制品研发和培养基供应效率,提升无血清细胞培养基的未来发展。

Great Bay Bio’s CHO-K1 Catalog Medium AlfaMedX- K1 (Growth Factor–Free) Achieves FDA DMF Filing
2026-03-09

Kingsley Leung, Chairman of Great Bay Bio, Awarded the FHKI X OCBC Hong Kong Innopreneur Awards 2025, Recognizing Outstanding Innovation
2025-11-14

Great Bay Bio and Taron Form Strategic Partnership to Advance HK Biopharmaceutical Innovation
2025-11-11